An experimental drug appears to help women deal with stress incontinence, clinical trial data show. The drug, for now dubbed TAS-303, reduced the frequency of leaks related to stress incontinence by about 58%, compared with 47% reduction in a placebo group, trial results show. Further, about 65% of patients taking TAS-303 had their stress incontinence…  read on >  read on >

Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator, a new report warns. In the report, published Thursday by the U.S. Centers for Disease Control and Prevention, researchers provided alarming details of patients getting injections outside of a…  read on >  read on >

U.S. health officials have determined that untreated water used by a Florida cucumber grower is one likely source of salmonella poisoning that sickened nearly 450 people this spring. Still, that grower didn’t supply all the cucumbers that were linked to salmonella contamination, the U.S. Food and Drug Administration (FDA) noted in a recent health update. During their…  read on >  read on >

Mounjaro outperforms Ozempic in helping people lose weight, a new study shows. People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (Ozempic, Wegovy), researchers reported July 8 in the journal JAMA Internal Medicine. “Individuals with overweight or obesity treated with tirzepatide were significantly more likely to achieve clinically meaningful weight loss…  read on >  read on >

In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers. In a study published July 5 in JAMA Network Open, researchers found people with type 2 diabetes who were being treated with a class of…  read on >  read on >